Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
BioThrax
Manufacturing
FDA signs off on Emergent's anthrax vaccine Cyfendus
Four years after Emergent began supplying its anthrax vaccine to the U.S., it has been fully approved by the FDA and branded as Cyfendus.
Kevin Dunleavy
Jul 21, 2023 10:49am
Emergent's founder will retire April 1
Jan 14, 2022 11:45am
Acquisitive Emergent BioSolutions buys PaxVax for $270M
Aug 13, 2018 12:25pm
Dynavax, Emergent and more—News of Note
Aug 8, 2018 7:59am
GSK's Mosquirix, Emergent BioSolutions and more—News of Note
Apr 18, 2018 9:57am
